상세 보기
Pyramax, an oral therapeutic candidate for the treatment of mild to moderate COVID-19: a multi-center, randomized, double-blind, parallel, placebo-controlled, phase 2 clinical trial
Pyramax, an oral therapeutic candidate for the treatment of mild to moderate COVID-19: a multi-center, randomized, double-blind, parallel, placebo-controlled, phase 2 clinical trial
- 제목
- Pyramax, an oral therapeutic candidate for the treatment of mild to moderate COVID-19: a multi-center, randomized, double-blind, parallel, placebo-controlled, phase 2 clinical trial
- 제목 (타언어)
- Pyramax, an oral therapeutic candidate for the treatment of mild to moderate COVID-19: a multi-center, randomized, double-blind, parallel, placebo-controlled, phase 2 clinical trial
- 저자
- CHOI, WONSEOK
- 발행일
- 2022-04-14
- 학회명
- 2022 대한항균요법학회 대한감염학회 춘계학술대회
- 개최국가
- 대한민국
- 학회 개최일
- 2022-04-14 ~ 2022-04-15